tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

URGN Stock Latest News

Urogen Pharma (URGN) Q4 Earnings Cheat Sheet
Pre-EarningsUrogen Pharma (URGN) Q4 Earnings Cheat Sheet
1d ago
URGN
Urogen Pharma’s Strategic Acquisitions and Pipeline Developments Drive Buy Rating with $64 Price Target
PremiumRatings
Urogen Pharma’s Strategic Acquisitions and Pipeline Developments Drive Buy Rating with $64 Price Target
12d ago
URGN
UroGen Pharma acquires ICVB-1042 from IconOVir Bio for $19M in cash, shares
PremiumThe Fly
UroGen Pharma acquires ICVB-1042 from IconOVir Bio for $19M in cash, shares
17d ago
URGN
UroGen Pharma transferred with Buy rating at Ladenburg
PremiumThe Fly
UroGen Pharma transferred with Buy rating at Ladenburg
18d ago
URGN
UroGen announces results from subgroup analyses of ENVISION trial
PremiumThe Fly
UroGen announces results from subgroup analyses of ENVISION trial
23d ago
URGN
UroGen Pharma announces results from long-term Jelmyto follow-up study
PremiumThe FlyUroGen Pharma announces results from long-term Jelmyto follow-up study
25d ago
URGN
UroGen Pharma reports ENVISION results to be published in The Journal of Urology
Premium
The Fly
UroGen Pharma reports ENVISION results to be published in The Journal of Urology
2M ago
URGN
UroGen Pharma Highlights RTGel® Platform and Growth Plans
Premium
Company Announcements
UroGen Pharma Highlights RTGel® Platform and Growth Plans
2M ago
8K
URGN
UroGen Pharma presents long-term, follow-up Jelmyto study data
PremiumThe Fly
UroGen Pharma presents long-term, follow-up Jelmyto study data
3M ago
URGN
UroGen Pharma: UGN-102 showed ‘promising’ results in Phase 3 Envision trial
PremiumThe Fly
UroGen Pharma: UGN-102 showed ‘promising’ results in Phase 3 Envision trial
3M ago
URGN
UroGen Pharma publishes long-term Jelmyto follow-up study results
PremiumThe Fly
UroGen Pharma publishes long-term Jelmyto follow-up study results
3M ago
URGN
UroGen Pharma Reports Q3 Results and Drug Progress
PremiumCompany Announcements
UroGen Pharma Reports Q3 Results and Drug Progress
4M ago
URGN
UroGen Pharma reports Q3 EPS (55c), consensus (82c)
PremiumThe FlyUroGen Pharma reports Q3 EPS (55c), consensus (82c)
4M ago
URGN
UroGen Pharma price target raised to $64 from $60 at H.C. Wainwright
Premium
The Fly
UroGen Pharma price target raised to $64 from $60 at H.C. Wainwright
5M ago
URGN
UroGen Pharma announces FDA acceptance of new drug application for UGN-102
Premium
The Fly
UroGen Pharma announces FDA acceptance of new drug application for UGN-102
5M ago
URGN
UroGen Pharma initiated with a Buy at EF Hutton
PremiumThe Fly
UroGen Pharma initiated with a Buy at EF Hutton
5M ago
URGN
UroGen Pharma Announces CFO Transition and Compensation Details
PremiumCompany Announcements
UroGen Pharma Announces CFO Transition and Compensation Details
5M ago
8K
URGN
UroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
PremiumThe Fly
UroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
5M ago
GRTX
URGN
UroGen Pharma: Patient dosed in mitomycin-based UGN-103 trial for LG-IR-NMIBC
PremiumThe Fly
UroGen Pharma: Patient dosed in mitomycin-based UGN-103 trial for LG-IR-NMIBC
5M ago
URGN
UroGen Pharma receives new U.S. patent allowance for RTGel technology
PremiumThe FlyUroGen Pharma receives new U.S. patent allowance for RTGel technology
6M ago
URGN
UroGen Pharma management to meet with Oppenheimer
Premium
The Fly
UroGen Pharma management to meet with Oppenheimer
6M ago
URGN
UroGen Pharma initiated with a Buy at Guggenheim
Premium
The Fly
UroGen Pharma initiated with a Buy at Guggenheim
7M ago
URGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >